By spending $1bn, Amazon made $14bn disappear. The money that went missing was not Amazon’s, though. That sum was the loss in market value at the biggest players in US drug distribution and retailing, after Amazon announced on Thursday that it would spend that billion to buy online pharmacist PillPack. Shares in those six companies (Walgreens, Boots Alliance, CVS Health, Express Scripts, Cardinal Health, McKesson, and AmerisourceBergen) had been depressed last year by the very suggestion that Amazon was coming into their territory. Proof positive trimmed their values by as much as 10 per cent.
亞馬遜(Amazon)斥資10億美元，卻讓140億美元蒸發(fā)。不過，損失的不是亞馬遜，而是美國最大幾家藥品分銷與零售企業(yè)的市值，此前，亞馬遜在上周四宣布，將斥資10億美元購買在線藥房PillPack。去年，有關亞馬遜即將進軍藥品零售業(yè)的傳言曾導致6家藥品經(jīng)銷商——沃博聯(lián)(Walgreens Boots Alliance)、CVS Health、快捷藥方(Express Scripts)、卡地納健康(Cardinal Health)、麥克森(McKesson)及美源伯根(AmericisourceBergen)——股價下挫。確鑿的消息令它們的市值縮水高達10%。